NOD2 and Blau syndrome: However, subsequent genetic analyses have shown that many patients with EOS have mutations in NOD2[3-6] and these two diseases and other variant forms are now considered to represent a pathophysiologically identical condition in which increased NFκB activity driven by mutated NOD2 gene plays a significant role[3,6-11].